Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein S-palmitoylation is a reversible lipid modification in which a palmitoyl group is attached to the sulfur atom of cysteine residues in target proteins via a thioester bond. This modification is catalyzed by DHHC-family palmitoyltransferases and reversed by acyl-protein thioesterases. S-palmitoylation regulates diverse protein functions, including membrane association, stability, localization, trafficking, and protein-protein interactions. It is essential in processes such as signal transduction, immune response, and synaptic function. Dysregulation of protein S-palmitoylation is implicated in numerous pathological conditions, notably cancer, neurodegenerative, cardiovascular, and immune-mediated diseases. Pharmacological modulation of S-palmitoylation is an emerging area in therapeutic development, though non-specificity and safety remain major challenges
Inhibition of S-palmitoylation via DHHC-palmitoyltransferase blockade (e.g., 2-BP inhibits the enzyme family responsible for palmitoylation)\nModulation of immune signaling, tumor signaling pathways, and protein localization through altered palmitoylation status
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein S-palmitoylation (null).